Detalhe da pesquisa
1.
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry.
Haematologica
; 109(1): 115-128, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37199127
2.
Emerging FLT3 inhibitors for the treatment of acute myeloid leukemia.
Expert Opin Emerg Drugs
; 27(1): 1-18, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35076348
3.
Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.
Pharmacogenet Genomics
; 31(6): 133-139, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33675324
4.
Healthcare resource utilization in adult patients with relapsed/refractory FLT3 mutated acute myeloid leukemia: A retrospective chart review from Spain.
Eur J Haematol
; 106(5): 724-733, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33609315
5.
Gilteritinib use in the treatment of relapsed or refractory acute myeloid leukemia with a FLT3 mutation.
Future Oncol
; 17(2): 215-227, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32975130
6.
Extracorporeal photopheresis vs standard therapies for steroid-refractory chronic graft-vs-host disease: Pharmacoeconomic assessment of hospital resource use in Spain.
J Clin Apher
; 36(4): 612-620, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33964038
7.
Drug-drug interactions of newly approved small molecule inhibitors for acute myeloid leukemia.
Ann Hematol
; 99(9): 1989-2007, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32683457
8.
Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.
J Oncol Pharm Pract
; 26(8): 1829-1835, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32063104
9.
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape.
Expert Rev Clin Pharmacol
; 16(2): 133-148, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708283
10.
Developing a telepharmacy programme with home medication dispensing and informed delivery in a tertiary hospital: description of the model and analysis of the results.
Eur J Hosp Pharm
; 30(2): 107-112, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35444000
11.
Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia.
Cancers (Basel)
; 15(8)2023 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190195
12.
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia.
Pharmaceutics
; 14(4)2022 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35456712
13.
Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus.
Medicine (Baltimore)
; 101(49): e32208, 2022 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36626459
14.
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study.
Cancers (Basel)
; 14(8)2022 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35454828
15.
Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
Leuk Lymphoma
; 62(3): 659-668, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33135528
16.
Evolving patterns of care and outcomes in relapsed/refractory FLT3 mutated acute myeloid leukemia adult patients.
Leuk Lymphoma
; 62(11): 2727-2736, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34121593
17.
Precision medicine in acute myeloid leukemia: where are we now and what does the future hold?
Expert Rev Hematol
; 13(10): 1057-1065, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32869672